WASHINGTON - Pfizer says kid-size doses of its COVID-19 vaccine are safe and nearly 91% effective at preventing infections in elementary school children.Details of the study were posted online Friday as U.S.
regulators consider opening vaccinations to youngsters 5 to 11.The shots could begin early next month -- with the first children in line fully protected by Christmas -- if regulators give the go-ahead.The Food and Drug Administration is expected to post its initial review of the company’s safety and effectiveness data later Friday.
Next week, advisers to the FDA will publicly debate the evidence.A 12-year-old boy receives a dose of the Pfizer-BioNTech Covid-19 vaccine on Sept.